The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

Area of Science:

• Immunology and Rheumatology
• Biomolecular Pathways
• Therapeutic Development

Background:

• Rheumatoid arthritis (RA) is a severe autoimmune disease with significant physical, emotional, and socioeconomic impacts.
• Current biologic and pharmacologic treatments offer advancements but often result in inadequate patient response or intolerable side effects.
• Disease progression persists in many RA patients despite existing interventions.

Purpose of the Study:

• To review biomolecular pathways implicated in rheumatoid arthritis pathogenesis.
• To elucidate and highlight current and emerging therapeutic targets for RA management.
• To provide an updated account of pharmacological treatments, including their discovery, mechanisms, efficacy, and limitations.

Main Methods:

• Comprehensive literature review of RA pathogenesis.
• Analysis of approved and emerging pharmacological RA treatments.
• Exploration of bioengineering and cell therapy concepts for future RA interventions.

Main Results:

• Multiple biomolecular pathways are identified as critical targets in RA.
• Current treatments demonstrate varied efficacy and limitations, necessitating further research.
• Emerging bioengineering and cell therapy approaches show promise for localized, targeted RA treatment.

Conclusions:

• Understanding RA's complex biomolecular pathways is crucial for effective treatment.
• Despite progress, significant unmet needs remain for RA patients.
• Future RA therapies may involve innovative bioengineering and cell-based strategies to improve localized treatment and reduce systemic side effects.